Primary debulking surgery in stage IIIC and IV ovarian cancer results in improved survival compared to those undergoing neoadjuvant chemotherapy with interval cytoreduction

Clark, Rachel

225 - Poster Session A
Primary debulking surgery in stage IIIC and IV ovarian cancer results in improved survival compared to those undergoing neoadjuvant chemotherapy with interval cytoreduction

Saturday, March 22, 2014: 2:05 PM

West Exhibit Hall (Tampa Convention Center)

R. M. Clark¹, J. T. Clemmer¹, A. Melamed², J. A. Rauh-Hain¹, N. Joseph¹, D. M. Boruta II¹, M. G. Del Carmen¹, A. Goodman¹, W. B. Growdon³ and J. O. Schorge¹
¹Massachusetts General Hospital/Harvard University, Boston, MA, ²Brigham and Women's Hospital/Massachussets General Hospital, Boston, MA, ³Massachusetts General Hospital, Boston, MA

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

225 - Poster Session A
Primary debulking surgery in stage IIIC and IV ovarian cancer results in improved survival compared to those undergoing neoadjuvant chemotherapy with interval cytoreduction

225 - Poster Session A Primary debulking surgery in stage IIIC and IV ovarian cancer results in improved survival compared to those undergoing neoadjuvant chemotherapy with interval cytoreduction

225 - Poster Session A
Primary debulking surgery in stage IIIC and IV ovarian cancer results in improved survival compared to those undergoing neoadjuvant chemotherapy with interval cytoreduction